Analyst firms · H.C. Wainwright · HUMA
H.C. Wainwright HUMA price target and rating history
Humacyte Inc. (HUMA) · Health Care
H.C. Wainwright rates Humacyte Inc. (HUMA) Buy with a $4 price target, as of its latest action on May 14, 2025. It has published 3 rating actions on HUMA since December 2023, including 0 upgrades and 0 downgrades.
- Current rating
- Buy
- Price target
- $4
- Median target, all firms
- Too few
- Actions on HUMA
- 3
H.C. Wainwright price target on HUMA
Every H.C. Wainwright rating on HUMA
- May 14, 2025
- Dec 20, 2024
- Dec 11, 2023
Questions about H.C. Wainwright and HUMA
- What is H.C. Wainwright's price target for HUMA?
- H.C. Wainwright's latest stated price target for Humacyte Inc. (HUMA) is $4, from its action on May 14, 2025.
- What is H.C. Wainwright's rating on HUMA?
- H.C. Wainwright rates HUMA Buy, a bullish rating, as of May 14, 2025.
- When did H.C. Wainwright last change its view on HUMA?
- On May 14, 2025, H.C. Wainwright resumes coverage at Buy, price target $4.
More HUMA rating histories
All H.C. Wainwright ratingsHUMA news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.